Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-08 | 2024-02-23 | 212934 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-22 | 2024-02-23 | 214235 |
| APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-04 | 2024-12-06 | 239364 |
| APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-18 | 2024-10-25 | 240639 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2024-06-13 | 2024-09-06 | 230469 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2024-06-13 | 2024-08-30 | 230474 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2017-09-04 | 2018-01-19 | 20915 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-11-10 | 2023-11-24 | 209933 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2022-07-15 | 2022-09-01 | 164754 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-11-04 | 2022-11-25 | 173812 |
| APO-ZOPICLONE | 5MG | TABLET | Resolved | 2023-12-15 | 2024-02-23 | 213565 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-12-22 | 2024-02-23 | 214229 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-03-30 | 2023-05-26 | 188421 |
| APO-ZOPICLONE | 7.5MG | TABLET | Resolved | 2023-04-06 | 2023-05-26 | 188946 |
| APO-ZOPICLONE - TAB 7.5MG | 7.5MG | TABLET | Resolved | 2017-08-16 | 2017-10-19 | 19558 |
| APO-ZOPICLONE - TAB 7.5MG | 7.5MG | TABLET | Resolved | 2017-09-04 | 2017-10-18 | 20912 |
| APO-ZOPICLONE - TAB 7.5MG | 7.5MG | TABLET | Resolved | 2018-08-27 | 2018-10-05 | 59308 |
| BACKUP PLAN ONESTEP | 1.5MG | TABLET | Resolved | 2023-09-22 | 2023-10-20 | 205012 |
| BACKUP PLAN ONESTEP | 1.5MG | TABLET | Resolved | 2019-02-13 | 2019-02-21 | 75635 |
| BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2025-04-10 | 2025-04-17 | 254841 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |